Ricardo Monteiro is a Junior Researcher at the Institute for Research and Innovation in Health (i3S) in the Host-Parasite Interactions group coordinated by Professor Joana Tavares. His passion for science began early during the degree in Biomedical Sciences at the University of Aveiro. After graduation, he moved to the School of Health of Polytechnic Institute of Porto to pursue his Master's Degree in Pharmacy and during the second year he also went to the Cellular and Molecular Pharmacology lab of the University of Bologna where he led his thesis project investigating the effects of resveratrol on the regulation of transcription factors REST and FoxO3 in medulloblastoma cells. After graduation in 2020, Ricardo worked as a Research Fellow in the Parasite Disease group at i3S, contributing to multiple projects. He began his PhD in Pharmaceutical Sciences in 2021 based on the characterization of the cellular and antibody responses to COVID-19 vaccines in immunocompromised individuals and upon completion of his doctoral studies he started working on the project "Pre-clinical development of promising scaffolds for Leishmaniasis". Currently, he is postdoc on the project "FLAVIVACCINE - Development and characterization of a pan-flavivirus vaccine candidate". Ricardo has contributed for 1 research article and about 24 communications for national and international conferences. He has attended several specialized meetings and conferences on immunology, virology and parasitology. Additionally, he co-supervised 2 undergraduate students and 1 Master's student.